Gen QA

MEMBER LOGIN

MENU menu

Close close menu

Calendar

The summary EQA timetable can be downloaded HERE.  The calendar below includes all EQA open/close dates and other GenQA events. 

EQA Catalogue Groups

(Click on a colour/icon to filter calendar entries)

Clinical Genetics and Genetic Counselling

Genomic and Inherited Disorders

Haematological Neoplasms

Individual Competency Assessment

Molecular Newborn Screening

Molecular Pathology

Multidisciplinary team (MDT) working

Pharmacogenomics

Preimplantation Genetic Testing (PGT)

Reproductive Genomics

Sample Handling

Technical (Next Generation Sequencing)

Variant Classification

Viral Sequencing

Other Events

GenQA EQA Enrolment Event

GenQA EQA Distribution Event

GenQA webinar

Conference

GenQA workshop

GenQA Participant meeting

GenQA office closed

Other

 

«prev
April 2026
next»
Sun Mon Tue Wed Thu Fri Sat
Sun 29
Mon 30
Tue 31
Wed 1
Thu 2
Fri 3
Sat 4
Sun 5
Mon 6
Tue 7
2026 Distribution 1

2026 Cystic Fibrosis (CF) Molecular Newborn screening (bloodspots) - round 1
- OPENS [more]
Testing Period: 4 weeks

2026 MCADD Molecular Newborn Screening (bloodspots) - round 1
- OPENS [more]
Testing Period: 4 weeks

2026 SCID Molecular Newborn Screening (bloodspots) - round 1
- OPENS [more]
Testing Period: 4 weeks

2026 Spinal Muscular Atrophy (SMA) Molecular Newborn screening (bloodspots) - round 1
- OPENS [more]
Testing Period: 4 weeks

2026 Chromosome instability syndromes
- OPENS [more]
Testing Period: 8 weeks

2026 Developmental Delay
- OPENS [more]
Testing Period: 8 weeks

2026 Differences in Sex Development (DSD)
- OPENS [more]
Testing Period: 8 weeks

2026 Hypotonic Infant
- OPENS [more]
Testing Period: 8 weeks

2026 Imprinting disorders
- OPENS [more]
Testing Period: 8 weeks

2026 Infertility
- OPENS [more]
Testing Period: 8 weeks

2026 Maternal cell contamination (MCC) & fetal sexing
- OPENS [more]
Testing Period: 6 weeks
Wed 8
Thu 9
Fri 10
Sat 11
Sun 12
Mon 13
2026 Distribution 2

2026 Colorectal cancer - core
- OPENS [more]
Testing Period: 6 weeks

2026 Colorectal cancer - MMR (MSI)
- OPENS [more]
Testing Period: 6 weeks

2026 Lung cancer - comprehensive (molecular)
- OPENS [more]
Testing Period: 6 weeks

2026 Lung cancer - EGFR only
- OPENS [more]
Testing Period: 6 weeks

2026 Melanoma
- OPENS [more]
Testing Period: 6 weeks

2026 Microsatellite instability testing (MSI)
- OPENS [more]
Testing Period: 6 weeks
Tue 14
Wed 15
Thu 16
Fri 17
2025 SARS-CoV-2 sequencing - Distribution 5989 - round 4
- CLOSES
Sat 18
Sun 19
Mon 20
2026 Distribution 3

2026 Cardiac disorders
- OPENS [more]
Testing Period: 18 weeks

2026 Epilepsy disorders
- OPENS [more]
Testing Period: 18 weeks

2026 Renal disorders
- OPENS [more]
Testing Period: 18 weeks

2026 Respiratory disorders
- OPENS [more]
Testing Period: 18 weeks
Tue 21
Wed 22
Thu 23
Fri 24
Sat 25
Sun 26
Mon 27
2026 Distribution 4

2026 Ataxia & Hereditary Spastic Paraplegia (HSP)
- OPENS [more]
Testing Period: 18 weeks

2026 Charcot Marie Tooth disease (CMT) and related sensory and motor neuropathies
- OPENS [more]
Testing Period: 7 weeks

2026 Eye disorders
- OPENS [more]
Testing Period: 7 weeks

2026 Familial colorectal cancer and polyposis
- OPENS [more]
Testing Period: 18 weeks

2026 Familial endocrine tumour predisposition disorders
- OPENS [more]
Testing Period: 7 weeks

2026 Familial Hypercholesterolaemia (FH)
- OPENS [more]
Testing Period: 7 weeks

2026 Gastroenterology and hepatology disorders
- OPENS [more]
Testing Period: 18 weeks

2026 Hereditary Breast and Ovarian Cancer (HBOC) disorders
- OPENS [more]
Testing Period: 18 weeks

2026 Inborn Errors of Metabolism (IEM)
- OPENS [more]
Testing Period: 18 weeks

2026 Mitochondrial disease
- OPENS [more]
Testing Period: 18 weeks

2026 Muscular dystrophies
- OPENS [more]
Testing Period: 18 weeks

2026 Neurodegenerative disorders
- OPENS [more]
Testing Period: 18 weeks

2026 Neurofibromatosis and rasopathies
- OPENS [more]
Testing Period: 7 weeks

2026 Parathyroid and Calcium Regulation disorders
- OPENS [more]
Testing Period: 7 weeks

2026 Primary Immunodeficiency disorders (PID)
- OPENS [more]
Testing Period: 18 weeks

2026 Skeletal dysplasia (including Osteogenesis Imperfecta)
- OPENS [more]
Testing Period: 18 weeks

2026 Variant Validation
- OPENS [more]
Testing Period: 18 weeks

2026 DNA quantification
- OPENS [more]
Testing Period: 3 weeks
Tue 28
Wed 29
Thu 30
BRCA-HRR Variant Classification Run 16 CLOSES
Fri 1
Sat 2